Docetaxel 20 mg/mL (Docetaxel Anhydrous INJECTION, SOLUTION) 20 mg/mL

Docetaxel 20 mg/mL is an intravenous solution used for various medical treatments. This medication, produced by Sagent Pharmaceuticals, is designed to support specific therapeutic needs. Learn more about its uses and effects.

Strength

20 mg/mL

Pack Size

1 VIAL in 1 CARTON (25021-245-01) / 1 mL in 1 VIAL

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Docetaxel 20 mg/mL is primarily used in the management of certain types of cancer. It is often prescribed as part of a treatment regimen to target cancer cells and inhibit their growth. Patients may wonder, 'What is Docetaxel used for?' This medication is typically administered intravenously and is intended for use under medical supervision.

Side Effects

Common effects of Docetaxel 20 mg/mL may include fatigue, nausea, and changes in blood cell counts. Some individuals might experience hair loss or mild allergic reactions. These effects can vary widely among patients and should be discussed with a healthcare provider.

Precautions & Warnings

Docetaxel 20 mg/mL should be handled with care, as it is a potent medication. It is important to follow proper storage and administration guidelines to ensure safety. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment.

Avoid Interactions

Docetaxel 20 mg/mL may interact with other medications, including those that affect the liver or immune system. It is advisable to avoid alcohol and certain supplements while undergoing treatment. Always consult a healthcare provider for personalized advice on managing potential interactions.

Frequently Asked Questions

Docetaxel is primarily used in the treatment of certain types of cancer, often as part of a combination therapy.

Docetaxel is administered intravenously, typically in a clinical setting under medical supervision.

Common side effects may include fatigue, nausea, hair loss, and changes in blood cell counts.

Docetaxel may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Precautions include following proper storage and administration guidelines, and informing healthcare providers of any existing medical conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.